Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 201

Results For "healthcare"

2087 News Found

Aurobindo Pharma calls off its acquisition of Cronus Pharma
News | August 21, 2021

Aurobindo Pharma calls off its acquisition of Cronus Pharma

The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market


Kauvery hospitals rope in Ms Dhoni as brand ambassador
News | August 20, 2021

Kauvery hospitals rope in Ms Dhoni as brand ambassador

Kauvery group of hospitals, a leading healthcare chain in Tamil Nadu, has roped in former Indian cricket captain Mahendra Singh Dhoni as its brand ambassador


Navia Life Care raises US $ 1 million in Series A funding
Startup | August 20, 2021

Navia Life Care raises US $ 1 million in Series A funding

The company plans to invest in technology, business development, product innovation, and development across India


Zydus ties up with CHEMI to launch Enoxaparin Sodium injection in the US
Drug Approval | August 20, 2021

Zydus ties up with CHEMI to launch Enoxaparin Sodium injection in the US

Enoxaparin Sodium Injection, USP is used for prophylaxis of Deep Vein Thrombosis (DVT) in patients undergoing abdominal, hip or knee replacement surgery, and also for the treatment of acute DVT


Health Minister Mr Manshuk Madaviya launch Aarogya Dhara 2.0
Policy | August 19, 2021

Health Minister Mr Manshuk Madaviya launch Aarogya Dhara 2.0

The government plans to enrol over 50 crore people and empanel more hospitals under the scheme. The scheme provides a cover of Rs 5 lakh per family per year


Semglee approval to provide huge opportunities in the US insulin biosimilar market
Biotech | August 19, 2021

Semglee approval to provide huge opportunities in the US insulin biosimilar market

FDA approval of the first interchangeable biosimilar insulin will drive the US Insulin biosimilar market, says Kuick Research.


ANG Lifesciences acquires Ind-Swift formulation facilities for Rs 60 cr
Biotech | August 18, 2021

ANG Lifesciences acquires Ind-Swift formulation facilities for Rs 60 cr

The company expects a potential sales turnover of Rs.350-500 crores at 100 % capacity utilization


Test At Home (TAH), offers convenient saliva-based testing for Covid-19
Drug Approval | August 18, 2021

Test At Home (TAH), offers convenient saliva-based testing for Covid-19

TAH is now undergoing regulatory clearance and final quality control procedures for the swab deployment in India, EU, Singapore, UK, US, Australia and others for COVID-19 testing


European Commission mandates InferVision AI to monitor Covid-19 variants
Digitisation | August 17, 2021

European Commission mandates InferVision AI to monitor Covid-19 variants

InferVision's AI applications have been developed to quickly and accurately analyse signs of pulmonary infections from regular chest CT images. These images are processed to indicate ground-glass opacity and high tissue density, which are key findings of viral pneumonia caused by the coronavirus


Nanavati Max is the first in Mumbai to receive NABH-MIS accreditation
Healthcare | August 16, 2021

Nanavati Max is the first in Mumbai to receive NABH-MIS accreditation

National Accreditation Board for Hospitals & Healthcare Providers (NABH) is a constituent board of the Quality Council of India, set up to establish and operate accreditation programmes for healthcare organisations